CHERRI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 152
EU - Europa 142
AS - Asia 21
OC - Oceania 2
Totale 317
Nazione #
US - Stati Uniti d'America 151
GB - Regno Unito 54
IE - Irlanda 32
IT - Italia 22
SE - Svezia 12
CN - Cina 8
VN - Vietnam 7
FR - Francia 6
UA - Ucraina 5
DE - Germania 4
IN - India 4
AU - Australia 2
BE - Belgio 2
ES - Italia 2
FI - Finlandia 2
IR - Iran 2
CA - Canada 1
RO - Romania 1
Totale 317
Città #
Southend 54
Dublin 32
Fairfield 27
Ashburn 15
Ann Arbor 14
Chandler 14
Seattle 14
Wilmington 8
Dong Ket 7
Houston 6
New York 6
Siena 6
Woodbridge 6
Cambridge 5
Jacksonville 4
Princeton 4
Milan 3
San Mateo 3
Beijing 2
Brussels 2
Helsinki 2
Málaga 2
Boardman 1
Brasov 1
Esslingen am Neckar 1
Fremont 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Langfang 1
Monteriggioni 1
Olgiate Olona 1
Pisa 1
Redwood City 1
Rome 1
Serra 1
Shanghai 1
Sydney 1
Vijayawada 1
Winnipeg 1
Xian 1
Zanjan 1
Totale 256
Nome #
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 161
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 87
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 82
Totale 330
Categoria #
all - tutte 1.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202045 0 0 0 0 0 0 10 14 11 4 3 3
2020/2021116 5 5 2 4 12 4 25 14 12 15 5 13
2021/202258 5 7 6 3 1 3 5 3 5 5 8 7
2022/202365 4 3 9 7 5 13 1 6 11 2 1 3
2023/202446 2 0 4 2 3 14 19 0 0 2 0 0
Totale 330